Correlation Between Inbar Group and Purple Biotech

Can any of the company-specific risk be diversified away by investing in both Inbar Group and Purple Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inbar Group and Purple Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Inbar Group Finance and Purple Biotech, you can compare the effects of market volatilities on Inbar Group and Purple Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inbar Group with a short position of Purple Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inbar Group and Purple Biotech.

Diversification Opportunities for Inbar Group and Purple Biotech

-0.23

Correlation Coefficient

Inbar Group  Purple Biotech

Very good diversification

The 3 months correlation between Inbar and Purple is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Inbar Group Finance and Purple Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Purple Biotech and Inbar Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inbar Group Finance are associated (or correlated) with Purple Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Purple Biotech has no effect on the direction of Inbar Group i.e., Inbar Group and Purple Biotech go up and down completely randomly.

Pair Corralation between Inbar Group and Purple Biotech

Assuming the 90 days trading horizon Inbar Group Finance is expected to generate 5.19 times more return on investment than Purple Biotech. However, Inbar Group is 5.19 times more volatile than Purple Biotech. It trades about 0.18 of its potential returns per unit of risk. Purple Biotech is currently generating about -0.09 per unit of risk. If you would invest  48,800  in Inbar Group Finance on December 2, 2024 and sell it today you would earn a total of  19,430  from holding Inbar Group Finance or generate 39.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Inbar Group Finance  vs.  Purple Biotech

Inbar Group Finance

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Inbar Group Finance are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Inbar Group sustained solid returns over the last few months and may actually be approaching a breakup point.

Purple Biotech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Purple Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Inbar Group and Purple Biotech

The main advantage of trading using opposite Inbar Group and Purple Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inbar Group position performs unexpectedly, Purple Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will offset losses from the drop in Purple Biotech's long position.

The idea behind Inbar Group Finance and Purple Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.